X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (63) 63
index medicus (55) 55
melanoma (46) 46
oncology (45) 45
female (30) 30
male (27) 27
melanoma - pathology (27) 27
melanoma - drug therapy (26) 26
middle aged (25) 25
aged (24) 24
cancer (22) 22
skin neoplasms - pathology (21) 21
adult (20) 20
skin neoplasms - drug therapy (19) 19
article (18) 18
metastasis (14) 14
metastatic melanoma (14) 14
mutation (14) 14
immunotherapy (13) 13
ipilimumab (13) 13
open-label (13) 13
treatment outcome (13) 13
animals (12) 12
antineoplastic agents - therapeutic use (12) 12
disease-free survival (12) 12
neoplasm staging (12) 12
proto-oncogene proteins b-raf - genetics (12) 12
aged, 80 and over (11) 11
antibodies, monoclonal - therapeutic use (11) 11
melanoma - therapy (11) 11
patients (11) 11
care and treatment (10) 10
clinical trials (10) 10
drug therapy (10) 10
melanoma - genetics (10) 10
melanoma - mortality (10) 10
skin neoplasms - therapy (10) 10
survival (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
braf (9) 9
chemotherapy (9) 9
dermatology (9) 9
proto-oncogene proteins b-raf - antagonists & inhibitors (9) 9
abridged index medicus (8) 8
cancer therapies (8) 8
malignant-melanoma (8) 8
melanoma - surgery (8) 8
molecular targeted therapy (8) 8
therapy (8) 8
trial (8) 8
cell biology (7) 7
disease progression (7) 7
follow-up studies (7) 7
hematology, oncology and palliative medicine (7) 7
improved survival (7) 7
medicine, research & experimental (7) 7
melanoma - immunology (7) 7
melanoma - secondary (7) 7
metastases (7) 7
mutations (7) 7
skin cancer (7) 7
adjuvant therapy (6) 6
antibodies, monoclonal - adverse effects (6) 6
antineoplastic agents - adverse effects (6) 6
chemotherapy, adjuvant (6) 6
drug dosages (6) 6
interferon (6) 6
kaplan-meier estimate (6) 6
medical research (6) 6
melanoma - metabolism (6) 6
neoplasm metastasis (6) 6
pharmacology & pharmacy (6) 6
phase-ii (6) 6
retrospective studies (6) 6
skin neoplasms - genetics (6) 6
skin neoplasms - surgery (6) 6
surgery (6) 6
vemurafenib (6) 6
young adult (6) 6
acquired-resistance (5) 5
antineoplastic agents - administration & dosage (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
brain neoplasms - secondary (5) 5
carcinoma, basal cell - drug therapy (5) 5
cooperative-oncology-group (5) 5
cutaneous melanoma (5) 5
efficacy (5) 5
genetic aspects (5) 5
high-risk melanoma (5) 5
medicine, general & internal (5) 5
melanoma - diagnosis (5) 5
neoplasms (5) 5
pathway (5) 5
radiation (5) 5
signal transduction (5) 5
skin neoplasms - immunology (5) 5
skin neoplasms - mortality (5) 5
toxicity (5) 5
tumors (5) 5
adjuvant radiotherapy (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2017, Volume 377, Issue 19, pp. 1824 - 1835
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2016, Volume 374, Issue 26, pp. 2542 - 2552
Journal Article
Melanoma Research, ISSN 0960-8931, 2016, Volume 26, Issue 5, pp. 535 - 539
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2018, Volume 379, Issue 8, pp. 722 - 730
Journal Article
JAMA, ISSN 0098-7484, 06/2014, Volume 311, Issue 23, pp. 2397 - 2405
Journal Article
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, 05/2018, Volume 38, Issue 38, pp. 759 - 762
In this article, we will focus on the practice-changing developments for stage III melanoma, from the use of the sentinel node (SN) biopsy to complete lymph... 
Immunotherapy - methods | Melanoma - pathology | Melanoma - surgery | Neoplasm Staging | Humans | Melanoma - drug therapy
Journal Article
Journal Article
Molecular Cell, ISSN 1097-2765, 08/2015, Volume 59, Issue 3, pp. 345 - 358
Journal Article
Journal Article